Elevated moral condemnation of third-party violations in multiple sclerosis patients. (4th May 2017)

• Record Type: Journal Article
• Authors: Patil, Indrajeet; Young, Liane; Sinay, Vladimiro; Gleichgerrcht, Ezequiel
• Is Part Of: Social neuroscience. Volume 12:Number 3(2017)
• Page Start: 308
• Page End: 329
• Publication Date: 2017-05-04
• Subjects: Morality -- punishment -- empathy -- alexithymia -- multiple sclerosis -- moral luck; Neurosciences -- Social aspects -- Periodicals; Neuropsychology -- Periodicals; Social psychology -- Periodicals; Social interaction -- Periodicals; 612.8
• DOI: 10.1080/17470919.2016.1175380
• Languages: English
• ISSNs: 1747-0919

Abstract

ABSTRACT: Recent research has demonstrated impairments in social cognition associated with multiple sclerosis (MS). The present work asks whether these impairments are associated with atypical moral judgment. Specifically, we assessed whether MS patients are able to integrate information about intentions and outcomes for moral judgment (i.e., appropriateness and punishment judgments) in the case of third-party acts. We found a complex pattern of moral judgments in MS patients: although their moral judgments were comparable to controls' for specific types of acts (e.g., accidental or intentional harms), they nevertheless judged behaviors to be less appropriate and endorsed more severe punishment across the board, and they were also more likely to report that others' responses would be congruent with theirs. Further analyses suggested that elevated levels of externally oriented cognition in MS (due to co-occurring alexithymia) explain these effects. Additionally, we found that the distinction between appropriateness and punishment judgments, whereby harmful outcomes influence punishment judgments to a greater extent than appropriateness judgments, was preserved in MS despite the observed disruptions in the affective and motivational components of empathy. The current results inform the two-process model for intent-based moral judgments as well as possible strategies for improving the quality of life in MS patients.